Clinical Trials Using EED Inhibitor MAK683

Clinical trials are research studies that involve people. The clinical trials on this list are studying EED Inhibitor MAK683. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

    The purpose of this Phase I / II study is to establish the maximum tolerated dose (MTD) and / or recommended phase 2 dose (RP2D) and to evaluate the safety, antitumor activity and pharmacokinetic (PK) profile of MAK683 in patients with advanced malignancies such as Diffuse Large B cell Lymphoma (DLBCL), nasopharyngeal carcinoma (NPC) or other advanced solid tumors for whom no further effective standard treatment is available.
    Location: 2 locations